Nantahala Capital Management »

Keros Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 322k 39.76
2023-09-30 $11M 341k 31.88
2023-06-30 $21M 510k 40.18
2023-03-31 $32M 755k 42.70
2022-12-31 $40M 834k 48.02
2022-09-30 $33M 888k 37.62
2022-06-30 $26M 954k 27.63
2022-03-31 $47M 859k 54.38
2021-12-31 $49M 836k 58.51
2021-09-30 $30M 760k 39.56
2021-06-30 $25M 599k 42.47
2021-03-31 $28M 460k 61.55
2020-12-31 $38M 535k 70.54
2020-09-30 $11M 277k 38.57
2020-06-30 $10M 275k 37.51